Illustration of a review approval workflow with documents passing through checkmarks and a stamp.

MLR Review for Pharma Marketing: What to Expect and How to Prepare

· 5 min read

Every pharma marketing team knows the acronym: MLR — medical, legal and regulatory review. It is the quality gate every piece of promotional content passes through before it can be published. This guide explains why it exists, what reviewers are looking for, and how to make the process faster.

Why MLR Review Exists

MLR review exists to make sure promotional content is accurate, balanced, and compliant before it reaches HCPs or the public. Each reviewer brings a different lens:

  • Medical review checks that claims are clinically accurate and supported by evidence.
  • Legal review checks that content meets regulatory and advertising requirements.
  • Regulatory review checks alignment with the relevant code or regulation (such as the ABPI Code or FDA rules).

What Reviewers Look For

Across all three disciplines, reviewers converge on a familiar set of questions:

  • Is every claim accurate and substantiated?
  • Is the material fairly balanced — is safety given comparable prominence to benefit?
  • Is the audience correct, and is the content appropriate for that audience?
  • Are adverse event reporting requirements addressed?
  • Is the content consistent with the approved labelling or SmPC?
  • Are references, sources, and the review trail complete?

Why Review Often Takes Too Long

Most MLR delays are not because reviewers are slow — they are because the first draft arrives needing structural fixes. When fair balance is missing, claims are overstretched, or references are absent, the reviewer is doing drafting work, not review work.

The fix is to start from a better first draft so the reviewer's time is spent refining, not rewriting.

How to Get Copy Approved Faster

Teams that move through MLR quickly tend to do a few things consistently:

  • Build the compliance structure in from the first draft — fair balance, disclaimers, references.
  • Brief reviewers clearly so they know the intended audience and channel.
  • Keep an evidence file ready so substantiation is quick to produce.
  • Address the common review comments before submission, not after.
  • Create reusable templates so each piece of content does not start from scratch.

How RegScribe Helps

RegScribe is built to get you a stronger first draft — ABPI-aware or FDA-aware, with fair-balance framing, a safety disclaimer, and a reference block on every variation. It is a drafting aid, not a substitute for MLR review, but it is designed to make that review faster.